Evidence map›Paper›PMID 31956523›Full record

ArticleWorld journal of psychiatry2020

Validity, reliability, and psychometric properties of a computerized, cognitive assessment test (Cognivue

Diego Cahn-Hidalgo, Paul W Estes, Reina Benabou

Registry-linked trialAbstract read
In one paragraph

Article in World journal of psychiatry, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04733989 (Development of a Biomarker Database to Investigate Aß, P-tau, and NfL Blood-Based Biomarkers and Digital Biomarkers in Older Participants Screened for Preclinical Alzheimer's Disease), which is not on this map. Cited by 22 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04733989 completednot on this mapstarted 2021, after this paper: background citation

Development of a Biomarker Database to Investigate Aß, P-tau, and NfL Blood-Based Biomarkers and Digital Biomarkers in Older Participants Screened for Preclinical Alzheimer's Disease (AD), Prodromal AD, or Mild AD

TypeobservationalSponsorGAP Innovations, PBCRan2021 to 2022Enrolled1,002ConditionsAlzheimer Disease, Alzheimer Disease, Early Onset, Mild Cognitive Impairment, Memory LossArmsBiomarker Data Collection
3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Cognitive Function 1 Year After COVID Infection.Open forum infectious diseases · 2025
    Article
  8. Review
  9. Article
  10. CognivueJournal of Alzheimer's disease : JAD · 2025
    Article
  11. Article
  12. Review
  13. Observational
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Diego Cahn-HidalgoInternal Medicine of Brighton, Rochester, NY 14623, United States.
Paul W EstesCognivue Inc., Victor, NY 14564, United States.
Reina BenabouCognivue Inc., Victor, NY 14564, United States.rbenabou@cognivue.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCognitive issues such as Alzheimer's disease and other dementias confer a substantial negative impact. Problems relating to sensitivity, subjectivity, and inherent bias can limit the usefulness of many traditional methods of assessing cognitive impairment.

aimTo determine cut-off scores for classification of cognitive impairment, and assess Cognivue

methodsAdults (age 55-95 years) at risk for age-related cognitive decline or dementia were invited

resultsFor the cut-off score determination study, 92 participants completed St. Louis University Mental Status (SLUMS, reference standard) and Cognivue

conclusionCognivue

Indexed as

Cognitive screening testDementiaMemoryMotor controlPerceptual processingVisual salience

Identifiers

PMID31956523
PMCPMC6928378

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.